Biotest Aktiengesellschaft (BIO) — Net Asset Momentum
Biotest Aktiengesellschaft (BIO) recorded a net asset momentum of 6.4% as of December 2024, with net assets of €530.70 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See BIO defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Biotest Aktiengesellschaft Net Asset Momentum (2002–2024)
This chart tracks Biotest Aktiengesellschaft's year-over-year net asset growth across 23 annual reporting periods from 2002 to 2024. The most recent momentum reading is +6.4%, with net assets of €530.70 Million EUR as of December 2024. Read total liabilities of Biotest Aktiengesellschaft for a breakdown of total debt and financial obligations.
Annual Net Asset History for Biotest Aktiengesellschaft (2002–2024)
The table below shows the complete annual net asset history for Biotest Aktiengesellschaft from 2002 to 2024, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Biotest Aktiengesellschaft market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €530.70 Million | €1.43 Billion | €903.30 Million | ▲ +6.4% |
| 2023 | €498.90 Million | €1.41 Billion | €912.00 Million | ▲ +34.4% |
| 2022 | €371.10 Million | €1.20 Billion | €831.90 Million | ▼ -2.4% |
| 2021 | €380.40 Million | €1.10 Billion | €723.80 Million | ▼ -13.9% |
| 2020 | €441.60 Million | €1.13 Billion | €689.70 Million | ▼ -7.4% |
| 2019 | €476.90 Million | €1.11 Billion | €631.50 Million | ▼ -3.7% |
| 2018 | €495.20 Million | €1.04 Billion | €547.10 Million | ▲ +42.4% |
| 2017 | €347.80 Million | €978.50 Million | €630.70 Million | ▼ -3.6% |
| 2016 | €360.70 Million | €932.80 Million | €572.10 Million | ▼ -12.5% |
| 2015 | €412.30 Million | €962.70 Million | €550.40 Million | ▼ -14.1% |
| 2014 | €480.20 Million | €1.03 Billion | €552.40 Million | ▲ +4.2% |
| 2013 | €460.70 Million | €886.50 Million | €425.80 Million | ▲ +24.7% |
| 2012 | €369.43 Million | €682.35 Million | €312.91 Million | ▲ +6.6% |
| 2011 | €346.67 Million | €682.76 Million | €336.09 Million | ▲ +12.7% |
| 2010 | €307.61 Million | €632.34 Million | €324.73 Million | ▲ +14.0% |
| 2009 | €269.86 Million | €633.45 Million | €363.59 Million | ▲ +6.5% |
| 2008 | €253.37 Million | €592.04 Million | €338.67 Million | ▲ +12.2% |
| 2007 | €225.76 Million | €536.70 Million | €310.94 Million | ▲ +25.9% |
| 2006 | €179.31 Million | €374.01 Million | €194.69 Million | ▲ +6.1% |
| 2005 | €168.97 Million | €367.09 Million | €198.12 Million | ▲ +56.5% |
| 2004 | €107.97 Million | €358.27 Million | €250.31 Million | ▲ +4.5% |
| 2003 | €103.29 Million | €349.98 Million | €246.69 Million | ▼ -6.8% |
| 2002 | €110.79 Million | €371.99 Million | €261.20 Million | — |